| Pharmaceutical active ingredients: |
| Diatrizoate MeglumineDiatrizoate Sodium |
| Available forms, composition and doses of Angiovist 370: |
| Injectable; Injection; Diatrizoate Meglumine 66%; Diatrizoate Sodium 10% |
| Angiovist 370 medical category: |
| Human:Roentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08AA01 - Diatrizoic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Berlex Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Urovist Cysto | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Cysto Pediatric | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Meglumine | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Meglumine DIU / CT | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Angiovist 292 | Diatrizoate Meglumine; Diatrizoate Sodium | Berlex Laboratories |
| Diatrizoate-60 | Diatrizoate Meglumine; Diatrizoate Sodium | International Medication Systems |
| Gastrografin | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma; Bracco; Bristol-Myers Squibb |
| Gastrografina | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma |
| Gastrografine | Diatrizoate Meglumine; Diatrizoate Sodium | Bayer Schering Pharma |
| Gastrovist | Diatrizoate Meglumine; Diatrizoate Sodium | Berlex Laboratories |